Left ventricular end-diastolic diameter is an independent predictor of mortality in hemodialysis patients

Tomoko Inoue1, Tetsuya Ogawa, Yuko Iwabuchi

  • 1Department of Medicine, Kidney Center Department of Medicine, Medical Center East, Tokyo Women's Medical University, Tokyo, Japan.

Insights

Left ventricular end-diastolic diameter (LVDd) predicts mortality in hemodialysis patients. Increased LVDd is an independent risk factor for all-cause mortality, aiding in risk stratification and treatment guidance for chronic hemodialysis patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Echocardiography

Background:

  • Left ventricular (LV) dysfunction is common in hemodialysis (HD) patients.
  • Identifying predictors of mortality in this population is crucial for improved patient outcomes.

Purpose of the Study:

  • To investigate the predictive value of LV end-diastolic diameter (LVDd) for all-cause mortality in chronic HD patients.
  • To assess LVDd as a prognostic marker compared to other echocardiographic parameters.

Main Methods:

  • An observational cohort study involving 166 HD patients.
  • Analysis of LVDd measurements and correlation with 4-year all-cause mortality.
  • Multivariate analysis adjusting for clinical and echocardiographic factors.

Main Results:

  • Patients who did not survive had significantly greater LVDd values compared to survivors (5.06 ± 0.64 cm vs. 4.78 ± 0.71 cm).
  • An LVDd cut-off of 5.01 cm showed a sensitivity of 75.7% and specificity of 50.4% for predicting mortality.
  • Increased LVDd was an independent predictor of all-cause mortality (HR 2.363, P = 0.0013).

Conclusions:

  • Increased LVDd is a significant independent predictor of all-cause mortality in chronic HD patients.
  • LVDd measurement offers valuable prognostic information for risk stratification and guiding therapeutic strategies in HD patients.
  • LVDd may be a more effective predictor of mortality than other echocardiographic parameters in this cohort.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...